Clinical Trials in China / NCT06807372
Active, not recruiting
Observational
Validation of a Model for Predicting Duodenal Stump Leakage After Gastrectomy
NCT06807372 · tracked via the Priya Life Science China tracker
Condition(s) studied
Gastric Cancers
Study summary
This study aims to validate a machine learning model for predicting duodenal stump leakage after laparoscopic radical gastrectomy for gastric cancer.
Eligibility
Inclusion Criteria:
1. Aged older than 18 years and younger than 85 years
2. Primary gastric carcinoma confirmed by preoperative pathology result
3. Expected curative resection via laparoscopic distal or total gastrectomy and reconstruction via Billroth-II or Roux-en-Y anastomosis
4. American Society of Anesthesiologists (ASA) class I, II, or III
5. With full documents of preoperative examinations such as blood test and abdominal CT scanning
6. Written informed consent
Exclusion Criteria:
1. Pregnant or breastfeeding women.
2. Severe mental disorder or language communication disorder.
3. Other surgical procedures of gastrectomy is performed.
4. Interrupted of surgery for more than 30 minutes due to any cause.
5. Malignant tumors with other organs
6. Performed gastrectomy in the past
Primary outcome measure(s)
- Incidence of duodenal stump leakage — Within 30 days after operation
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Gastrointestinal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou | Zhejiang |
More Jichao Qin trials in China
Mesogastrium Metastasis in Colon Cancer
Recruiting
Other trials for the same condition
The Effect of Environmental Factors on Gastric Cancer Based on Macrogenome
Active, not recruiting
Predictive Value of Air Pollution and Metabolomics for Gastric Cancer.
Active, not recruiting
The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06807372 on ClinicalTrials.gov ↗ ← All trials in China